Hepoxilin analogs, potential new therapeutics in disease

Current Pharmaceutical Design
C R Pace-AsciakMohamed Abdelhaleem

Abstract

We have chemically synthesized several stable analogs of the naturally occurring hepoxilins, 12-LO products derived from arachidonic acid, which we found to have promising actions in a variety of test systems of disease. The analogs, PBTs, afford chemical and biological stability to the hepoxilin molecule. This article reviews some of our latest observations with the PBTs in the areas of inflammation (inhibition of the bleomycin-evoked lung fibrosis in mice in vivo), platelet aggregation (antagonism of the thromboxane receptor in human platelets in vitro) and thrombosis (inhibitors in vivo), and cancer (apoptosis of the human leukemia cell line, K562 in vitro and in vivo). The demonstration that the PBTs are active in vivo suggests that they can serve as a platform for their further development as novel therapeutics in disease.

Citations

Oct 19, 2011·Cancer Metastasis Reviews·Cecil R Pace-Asciak
Jul 5, 2007·The FEBS Journal·Santosh NigamRenate Roux-Van der Merwe
Sep 23, 2014·Biochimica Et Biophysica Acta·Cecil R Pace-Asciak

❮ Previous
Next ❯

Related Concepts

Related Feeds

Anti-inflammatory Treatments

A drug or substance that reduces inflammation (redness, swelling, and pain) in the body. Anti-inflammatory agents block certain substances in the body that cause inflammation and swelling. Discover the latest research on anti-inflammatory treatments here

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Biochemical and Biophysical Research Communications
Santosh Nigam, Maria-Patapia Zafiriou
Biochemical and Biophysical Research Communications
C R Pace-AsciakE J Corey
Biochemical and Biophysical Research Communications
C R Pace-AsciakW G Su
© 2021 Meta ULC. All rights reserved